Volume 20, Number 9—September 2014
Dispatch
Enhanced MERS Coronavirus Surveillance of Travelers from the Middle East to England
Helen Lucy Thomas, Hongxin Zhao, Helen K. Green, Nicola L. Boddington, Carlos F.A. Carvalho, Husam K. Osman, Carol Sadler, Maria Zambon, Alison Bermingham, and Richard G. Pebody
Table 2
Positive predictive value of signs and symptoms among 77 travelers from the Middle East tested for MERS-CoV, Enhanced MERS-CoV Surveillance System, England, September 2012–October 2013*
| Signs and symptoms |
No. MERS CoV–positive/no. tested |
Positive predictive value, %
(95% CI) |
|---|---|---|
| Fever, cough; no pulmonary parenchymal involvement | 0/3 | 0 (0–71†) |
| Fever, cough, and pulmonary parenchymal involvement | 2/18 | 11 (1–35) |
| Fever, cough, and pulmonary parenchymal involvement requiring mechanical ventilation | 2/4 | 50 (7–93) |
| Fever, cough, pulmonary parenchymal involvement, and acute respiratory distress syndrome | 2/4 | 50 (7–93) |
| Fever, cough, and pulmonary parenchymal involvement requiring extracorporeal membrane oxygenation | 2/2 | 100 (16–100) |
*MERS-CoV, Middle East respiratory syndrome coronavirus.
†1-sided, 97.5% CI.
Page created: August 14, 2014
Page updated: August 14, 2014
Page reviewed: August 14, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.